StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$0.81+0.01 (+1.06%)

Close on Nov 17, 2026Market cap $104.43MP/E –Yield –

Organogenesis cash

Cash and short-term investments held at the end of each period.

Organogenesis's cash was $46.10M at Jun 30, 2026. For fiscal 2025 it was $93.68M, down 31.2% from the year before. Over ten years it grew 54.6% a year on average. The highest annual figure on record is $136.15M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$93.68M-31.2%
FY2024Dec 31, 2024$136.15M+30.5%
FY2023Dec 31, 2023$104.34M+1.0%
FY2022Dec 31, 2022$103.29M-9.8%
FY2021Dec 31, 2021$114.53M+35.0%
FY2020Dec 31, 2020$84.81M+40.5%
FY2019Dec 31, 2019$60.37M+182.0%
FY2018Dec 31, 2018$21.41M+807.8%
FY2017Dec 31, 2017$2.36M+26.9%
FY2016Dec 31, 2016$1.86M+55.0%
FY2015Dec 31, 2015$1.20M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$46.10M-37.5%
Q1 FY2026Mar 31, 2026$91.38M-17.3%
Q4 FY2025Dec 31, 2025$93.68M-31.2%
Q3 FY2025Sep 30, 2025$63.75M-32.8%
Q2 FY2025Jun 30, 2025$73.74M-18.5%
Q1 FY2025Mar 31, 2025$110.53M+23.7%
Q4 FY2024Dec 31, 2024$136.15M+30.5%
Q3 FY2024Sep 30, 2024$94.93M-3.9%
Q2 FY2024Jun 30, 2024$90.48M+1.1%
Q1 FY2024Mar 31, 2024$89.35M-0.1%
Q4 FY2023Dec 31, 2023$104.34M+1.0%
Q3 FY2023Sep 30, 2023$98.83M-8.5%
Q2 FY2023Jun 30, 2023$89.51M-20.8%
Q1 FY2023Mar 31, 2023$89.42M-17.6%
Q4 FY2022Dec 31, 2022$103.29M-9.8%
Q3 FY2022Sep 30, 2022$108.02M+5.2%
Q2 FY2022Jun 30, 2022$112.94M+25.1%
Q1 FY2022Mar 31, 2022$108.50M+39.2%
Q4 FY2021Dec 31, 2021$114.53M+35.0%
Q3 FY2021Sep 30, 2021$102.72M+178.5%
Q2 FY2021Jun 30, 2021$90.31M+121.6%
Q1 FY2021Mar 31, 2021$77.96M+65.6%
Q4 FY2020Dec 31, 2020$84.81M+40.5%
Q3 FY2020Sep 30, 2020$36.89M+59.3%
Q2 FY2020Jun 30, 2020$40.75M+102.2%
Q1 FY2020Mar 31, 2020$47.07M+53.5%
Q4 FY2019Dec 31, 2019$60.37M+182.0%
Q3 FY2019Sep 30, 2019$23.16M-10.5%
Q2 FY2019Jun 30, 2019$20.16M+1438.9%
Q1 FY2019Mar 31, 2019$30.66M+3240.2%
Q4 FY2018Dec 31, 2018$21.41M+807.8%
Q3 FY2018Sep 30, 2018$25.89M+21888.8%
Q2 FY2018Jun 30, 2018$1.31M+357.3%
Q1 FY2018Mar 31, 2018$918.00K+88.8%
Q4 FY2017Dec 31, 2017$2.36M+26.9%
Q3 FY2017Sep 30, 2017$117.73K-31.5%
Q2 FY2017Jun 30, 2017$286.46K–
Q1 FY2017Mar 31, 2017$486.20K–
Q4 FY2016Dec 31, 2016$1.86M–
Q3 FY2016Sep 30, 2016$171.83K–

More Organogenesis figures

See a number that looks wrong?